-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, 13 multinational pharmaceutical companies disclosed their results for the first quarter of 2021.
First quarter results of 13 multinational pharmaceutical companies (US$100 million)
Johnson & Johnson's business mainly includes three modules, namely pharmaceutical business, medical device business and consumer health care business.
Johnson & Johnson's business mainly includes three modules, namely pharmaceutical business, medical device business and consumer health care business.
During the quarter, Roche successfully completed the transformation of product sales.
Pfizer’s revenue in the first quarter reached US$14.
Based on the 1.
As a result of the completion of the acquisition of Allergan in May 2020, AbbVie's 2020 revenue soared to 45.
Aslacon, Eli Lilly, and Gilead also saw double-digit revenue growth this quarter compared to last year, reaching 7.
The company with the worst revenue decline this quarter was GlaxoSmithKline (-18%), which saw declines in its pharmaceutical, vaccine, and consumer healthcare businesses.